Agilent Technologies, Inc. (Santa Clara, California) Completes Acquisition of Dako, Danish Cancer Diagnostics Company

Published: Jun 21, 2012

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE:A) today announced that its acquisition of cancer diagnostics company Dako has been completed. Agilent, which paid $2.2 billion in cash for Dako (on a debt-free basis), expects the acquisition to help strengthen Agilent’s position in life sciences, with a focus on product development to help in the fight against cancer.

Back to news